Sign-in Links
PHAR 480 Drug Discovery and Development Units: 3.00
This survey course covers the life-cycle of pharmaceutical products including discovery, development, and the transition to a generic or over-the-counter medication. Specific themes include target identification, design and synthesis, efficacy determination, optimization, preclinical safety assessment, clinical trials, and the differences between biologics and small chemical entities. Social and economic pressures exerted upon the pharmaceutical industry are also explored.
Requirements: Minimum 4th year (Level 4) standing and one of (PHAR 230/3.0; PHAR 370/3.0; PHAR 340/3.0). LISC MAJ & SSP students require a GPA of 2.5.
Note this course cannot be used as credit towards the LISC DDHT SSP Plan
Exclusion DDHT 459/3.0; DDHT 460/3.0
Offering Faculty: Faculty of Health Sciences
Course Learning Outcomes:
- Critically analyze the social and economic implications of legislative decisions pertaining to the pharmaceutical industry to argue a particular side of this these decisions.
- Develop solutions to drug discovery/development problems to discuss either orally or in writing solutions to these problems.
- Develop an understanding of the biologic, social, and economic constraints that influence drug discovery and drug development.
- Develop and refine professional interpersonal communication skills.